Text of US HB 1015 (2025)

I 119TH CONGRESS 1ST SESSION H. R. 1015 To amend title 18, United States Code, to provide for certain rules for housing or transportation based on gender and to provide for a limitation on gender-related medical treatment. IN THE HOUSE OF REPRESENTATIVES FEBRUARY 5, 2025 Ms. MACE (for herself, Mr. NEHLS, Mr. DONALDS, and Ms. BOEBERT) intro- duced the following bill; which was referred to the Committee on the Ju- diciary A BILL To amend title 18, United States Code, to provide for certain rules for housing or transportation based on gender and to provide for a limitation on gender-related medical treatment. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the ‘‘Prison Rape Preven- 4 tion Act of 2025’’. 5 VerDate Sep 11 2014 21:37 Mar 04, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1015.IH H1015 kjohnson on DSK7ZCZBW3PROD with $$_JOB 2 •HR 1015 IH SEC. 2. RULES FOR HOUSING OR TRANSPORTATION BASED 1 ON GENDER; LIMITATION ON GENDER-AF- 2 FIRMING CARE. 3 Section 3621 of title 18, United States Code, is 4 amended by adding at the end the following: 5 ‘‘(j) RULES FOR HOUSING OR TRANSPORTATION 6 BASED ON GENDER; LIMITATION ON GENDER-AFFIRMING 7 CARE.—Notwithstanding any other provision of law, the 8 Bureau of Prisons— 9 ‘‘(1) shall ensure that a prisoner is placed, dur- 10 ing that prisoner’s term of imprisonment, only 11 among prisoners of the same biological sex as the 12 prisoner; 13 ‘‘(2) shall ensure that a prisoner, when trans- 14 ported in the company of other prisoners, is only 15 transported among prisoners of the same biological 16 sex as the prisoner; and 17 ‘‘(3) may not furnish or pay for any gender-re- 18 lated medical treatment. 19 ‘‘(k) DEFINITIONS.—For purposes of subsection (j): 20 ‘‘(1) BIOLOGICAL SEX.—The term ‘biological 21 sex’ means the biological determination as to wheth- 22 er an individual is male or female. 23 ‘‘(2) FEMALE.—The term ‘female’ means an in- 24 dividual who naturally has, had, will have, or would 25 have, but for a developmental or genetic anomaly or 26 VerDate Sep 11 2014 06:23 Mar 05, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1015.IH H1015 kjohnson on DSK7ZCZBW3PROD with $$_JOB 3 •HR 1015 IH historical accident, the reproductive system that at 1 some point produces, transports, and utilizes eggs 2 for fertilization. 3 ‘‘(3) MALE.—The term ‘male’ means an indi- 4 vidual who naturally has, had, will have, or would 5 have, but for a developmental or genetic anomaly or 6 historical accident, the reproductive system that at 7 some point produces, transports, and utilizes sperm 8 for fertilization. 9 ‘‘(4) GENDER.—The term ‘gender’— 10 ‘‘(A) means— 11 ‘‘(i) males, females, or the natural dif- 12 ferences between males and females, unless 13 such term is otherwise specified or used 14 alone (rather than with or as an adjective 15 modifying other words); and 16 ‘‘(ii) a synonym for sex; and 17 ‘‘(B) does not mean a synonym for terms 18 or ideas such as gender identity, experienced 19 gender, gender expression, or gender roles 20 ‘‘(5) GENDER-RELATED MEDICAL TREAT- 21 MENT.—The term ‘gender-related medical treat- 22 ment’— 23 ‘‘(A) means— 24 VerDate Sep 11 2014 21:37 Mar 04, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H1015.IH H1015 kjohnson on DSK7ZCZBW3PROD with $$_JOB 4 •HR 1015 IH ‘‘(i) with respect to a female indi- 1 vidual, medical treatments provided for 2 purposes of addressing the perception of 3 such individual that the gender or sex of 4 such individual is not female, including— 5 ‘‘(I) surgical procedures, includ- 6 ing— 7 ‘‘(aa) vaginectomy; 8 ‘‘(bb) hysterectomy; 9 ‘‘(cc) oophorectomy; 10 ‘‘(dd) reconstruction of the 11 urethra; 12 ‘‘(ee) metoidioplasty; 13 ‘‘(ff) phalloplasty; 14 ‘‘(gg) salpingo- 15 oophorectomy; 16 ‘‘(hh) scrotoplasty; 17 ‘‘(ii) implantation of erection 18 or testicular protheses; 19 ‘‘(jj) subcutaneous mastec- 20 tomy; 21 ‘‘(kk) vocal cord surgery; 22 ‘‘(ll) pectoral implants; and 23 ‘‘(mm) penile transplan- 24 tation; 25 VerDate Sep 11 2014 21:37 Mar 04, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H1015.IH H1015 kjohnson on DSK7ZCZBW3PROD with $$_JOB 5 •HR 1015 IH ‘‘(II) exogenous doses of testos- 1 terone or other androgens; 2 ‘‘(III) puberty blockers, includ- 3 ing— 4 ‘‘(aa) GnRH agonists; and 5 ‘‘(bb) synthetic drugs that 6 suppress the production of estro- 7 gen and progesterone or delay or 8 suppress pubertal development in 9 female individuals; and 10 ‘‘(IV) such other medical treat- 11 ment, identified by the Director of the 12 Federal Bureau of Prisons, that may 13 be provided for purposes of addressing 14 the perception of such individual that 15 the gender or sex of such individual is 16 not female; and 17 ‘‘(ii) with respect to a male individual, 18 medical treatments provided for purposes 19 of addressing the perception of such indi- 20 vidual that the gender or sex of such indi- 21 vidual is not male, including— 22 ‘‘(I) surgical procedures, includ- 23 ing— 24 ‘‘(aa) penectomy; 25 VerDate Sep 11 2014 21:37 Mar 04, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H1015.IH H1015 kjohnson on DSK7ZCZBW3PROD with $$_JOB 6 •HR 1015 IH ‘‘(bb) orchiectomy; 1 ‘‘(cc) vaginoplasty; 2 ‘‘(dd) clitoroplasty; 3 ‘‘(ee) vulvoplasty; 4 ‘‘(ff) augmentation 5 mammoplasty; 6 ‘‘(gg) facial feminization 7 surgery; 8 ‘‘(hh) vocal cord surgery; 9 ‘‘(ii) chondrolaryngoplasty; 10 ‘‘(jj) gluteal augmentation; 11 and 12 ‘‘(kk) uterine transplan- 13 tation; 14 ‘‘(II) exogenous doses of estro- 15 gen; 16 ‘‘(III) puberty blockers, includ- 17 ing— 18 ‘‘(aa) GnRH agonists; and 19 ‘‘(bb) synthetic drugs that 20 suppress the production of testos- 21 terone or delay or suppress pu- 22 bertal development in male indi- 23 viduals; and 24 VerDate Sep 11 2014 21:37 Mar 04, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H1015.IH H1015 kjohnson on DSK7ZCZBW3PROD with $$_JOB 7 •HR 1015 IH ‘‘(IV) such other medical treat- 1 ment, identified by the Director of the 2 Federal Bureau of Prisons, that may 3 be provided for purposes of addressing 4 the perception of such individual that 5 the gender or sex of such individual is 6 not male; and 7 ‘‘(B) does not include any medical 8 treament performed on an individual for the 9 purposes of treating— 10 ‘‘(i) a disorder of sex development, di- 11 agnosed by a physician after such physi- 12 cian has determined through genetic or 13 biochemical testing that such individual 14 does not have normal sex chromosome 15 structure, sex steroid hormone production, 16 or sex steroid hormone action; 17 ‘‘(ii) irresolvably ambiguous biological 18 sex characteristics of such individual, in- 19 cluding the presence of— 20 ‘‘(I) 46 XX chromosomes with 21 virilization; 22 ‘‘(II) 46 XY chromosomes with 23 undervirilization; or 24 VerDate Sep 11 2014 21:37 Mar 04, 2025 Jkt 059200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H1015.IH H1015 kjohnson on DSK7ZCZBW3PROD with $$_JOB 8 •HR 1015 IH ‘‘(III) both ovarian and testicular 1 tissue; or 2 ‘‘(iii) an infection, injury, disease, or 3 disorder caused or exacerbated by gender- 4 related medical treatment that was fur- 5 nished to an individual.’’. 6 Æ VerDate Sep 11 2014 21:37 Mar 04, 2025 Jkt 059200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6301 E:\BILLS\H1015.IH H1015 kjohnson on DSK7ZCZBW3PROD with $$_JOB